Focusing on advanced stages of CKD (stages 3–5, n = 130) did not change the associations of GFR, EPO and ferritin with hepcidin levels, whereas hypertension and dyslipidemia lost significance (detailed data not shown). The gene discussed is EPO; the disease is metabolic syndrome.